Edwards Lifesciences (EW) Tops Q4 EPS by 1c; Guides Above the Street

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. WCN
7. SPOT
8. SPY
9. FIX
10. TSCO

Go back to Edwards Lifesciences (EW) Tops Q4 EPS by 1c; Guides Above the Street

Edwards Lifesciences Reports Fourth Quarter Results

February 2, 2016 4:15 PM EST

IRVINE, Calif., Feb. 2, 2016 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today reported financial results for the quarter ended December 31, 2015.

 

Fourth Quarter and Recent Highlights:

Global sales grew 8.6% to $671.1 million, and underlying1 sales were up 15.1%. Global THV sales grew 25.0%, and underlying sales were up 32.4%. Results reflect 2-for-1 stock split completed in December 2015. GAAP EPS was $0.64, an increase of 28.0%, and non-GAAP EPS grew... More